Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 May 2025
Review of medicines containing finasteride and dutasteride concluded Finasteride and dutasteride tablets: Measures to minimise risk of suicidal thoughtsFollowing an EU-wide…, Agenda Agenda of the PRAC meeting 5-8 May 2025DraftReference Number: EMA/PRAC/125561/2025 English (EN…, PRAC statistics: May 2025 , PRAC statistics: May 2025 English (EN) (103.83 KB - PDF)First published: 08/05/2025View, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…
Review of medicines containing finasteride and dutasteride concluded Finasteride and dutasteride tablets: Measures to minimise risk of suicidal thoughtsFollowing an EU-wide…, Agenda Agenda of the PRAC meeting 5-8 May 2025DraftReference Number: EMA/PRAC/125561/2025 English (EN…, PRAC statistics: May 2025 , PRAC statistics: May 2025 English (EN) (103.83 KB - PDF)First published: 08/05/2025View, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…
